Another small step for small vessels

If I've Heard It Once, I've Heard It (Not Yet) a Hundred Times

“…Everolimus bests paclitaxel [1]. Sirolimus and everolimus are not inferior to paclitaxel in diabetic patients as initially thought, probably not as good in smaller vessels [2]. All drug‐eluting stent costs are about the same give or take some contractual nuances and deliverability of the second generation stents are equally good, as well.…”